Cambridge Investment Research Advisors’s Annexon ANNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58K Hold
10,110
﹤0.01% 3975
2026
Q1
$56K Sell
10,110
-590
-6% -$3.32K ﹤0.01% 3845
2025
Q4
$54K Hold
10,700
﹤0.01% 3752
2025
Q3
$33K Hold
10,700
﹤0.01% 3672
2025
Q2
$26K Hold
10,700
﹤0.01% 3566
2025
Q1
$21K Sell
10,700
-500
-4% -$1.66K ﹤0.01% 3452
2024
Q4
$57K Sell
11,200
-200
-2% -$1.23K ﹤0.01% 3368
2024
Q3
$67K Buy
11,400
+83
+0.7% +$492 ﹤0.01% 3309
2024
Q2
$55K Buy
11,317
+617
+6% +$3.19K ﹤0.01% 3209
2024
Q1
$77K Buy
10,700
+700
+7% +$3.63K ﹤0.01% 3176
2023
Q4
$45K Hold
10,000
﹤0.01% 3105
2023
Q3
$24K Hold
10,000
﹤0.01% 3075
2023
Q2
$35K Hold
10,000
﹤0.01% 3105
2023
Q1
$39K Hold
10,000
﹤0.01% 3063
2022
Q4
$52K Hold
10,000
﹤0.01% 2973
2022
Q3
$62K Hold
10,000
﹤0.01% 2916
2022
Q2
$38K Buy
+10,000
New +$30.6K ﹤0.01% 2962

Other funds holding ANNX

Cambridge Investment Research Advisors's ANNX Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its Annexon (ANNX) position steady in Q2 2026 at 10,110 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #3975.

Cambridge Investment Research Advisors first reported a position in ANNX in Q2 2022 and has held it in 17 quarters since. The position peaked at $77K in Q1 2024. 216 funds tracked by Wall St. Rank hold ANNX as of Q2 2026.

  • Cambridge Investment Research Advisors held 10,110 shares of Annexon worth $58K as of Q2 2026.
  • Cambridge Investment Research Advisors left its Annexon share count unchanged in Q2 2026.
  • Annexon made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3975 holding.
  • Cambridge Investment Research Advisors first reported a position in Annexon in Q2 2022 and has held it in 17 quarters since.
  • Cambridge Investment Research Advisors's Annexon position peaked at $77K in Q1 2024.
  • 216 funds tracked by Wall St. Rank held Annexon as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.